Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
Nature Cancer
|
May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
Chaping Cheng, Jinming Wang, Penghui Xu, et al.
Epigenomics
|
September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions
Yuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Elife
|
February 9, 2026
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1<sup>+</sup> TAMs
Fangyuan Dong, Shan Zhang, Kaiyuan Song, et al.
Cancer Discovery
|
December 19, 2025
Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogramming
Yiyi Ji, Cheng-Wei Ju, Lei Chen, et al.
The Journal of Experimental Medicine
|
July 19, 2021
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
Satoshi Nakamizo, Charles-Antoine Dutertre, Ahad Khalilnezhad, et al.
Nature Cancer
|
March 18, 2025
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway
Jinming Wang, Penghui Xu, Zhongzhong Ji, et al.
Neuron
|
May 8, 2026
A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma
Shan Zhang, Fang-Yuan Dong, Shuqi Cai, et al.
Nature
|
March 31, 2022
Obesity alters pathology and treatment response in inflammatory disease
Sagar P Bapat, Caroline Whitty, Cody T Mowery, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
Nature Cancer
|
May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
Chaping Cheng, Jinming Wang, Penghui Xu, et al.
Epigenomics
|
September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions
Yuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Elife
|
February 9, 2026
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1<sup>+</sup> TAMs
Fangyuan Dong, Shan Zhang, Kaiyuan Song, et al.
Cancer Discovery
|
December 19, 2025
Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogramming
Yiyi Ji, Cheng-Wei Ju, Lei Chen, et al.
The Journal of Experimental Medicine
|
July 19, 2021
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
Satoshi Nakamizo, Charles-Antoine Dutertre, Ahad Khalilnezhad, et al.
Nature Cancer
|
March 18, 2025
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway
Jinming Wang, Penghui Xu, Zhongzhong Ji, et al.
Neuron
|
May 8, 2026
A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma
Shan Zhang, Fang-Yuan Dong, Shuqi Cai, et al.
Nature
|
March 31, 2022
Obesity alters pathology and treatment response in inflammatory disease
Sagar P Bapat, Caroline Whitty, Cody T Mowery, et al.
Page
of 13